Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity

v3.23.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2020 $ 3 $ 87,051 $ (83,878) $ (52) $ 3,124
Balance (in Shares) at Dec. 31, 2020 26,859,850        
Issuance of common stock, net of offering costs of $4.1 million $ 1 35,890 35,891
Issuance of common stock, net of offering costs of $4.1 million (in Shares) 10,000,000        
Issuance of common stock to service provider 600 600
Issuance of common stock to service provider (in Shares) 120,000        
Issuance of common stock warrants 395 395
Net exercise of warrants
Net exercise of warrants (in Shares) 162,507        
Issuance of common stock in connection with exercise of warrants 4 4
Issuance of common stock in connection with exercise of warrants (in Shares) 4,208        
Exercise of common stock options 152 152
Exercise of common stock options (in Shares) 240,907        
Stock-based compensation expense 1,387 1,387
Foreign currency translation adjustment (18) (18)
Net loss (17,464) (17,464)
Balance at Dec. 31, 2021 $ 4 125,479 (101,342) (70) 24,071
Balance (in Shares) at Dec. 31, 2021 37,387,472        
Issuance of common stock warrants 72 72
Exercise of common stock options 30 30
Exercise of common stock options (in Shares) 55,191        
Stock-based compensation expense 2,112 2,112
Foreign currency translation adjustment (370) (370)
Net loss (24,449) (24,449)
Balance at Dec. 31, 2022 $ 4 $ 127,693 $ (125,791) $ (440) $ 1,466
Balance (in Shares) at Dec. 31, 2022 37,442,663